Search

Author/Creator Goebeler, Maria‐Elisabeth

1. Phase I study of domatinostat (4SC‐202), a class I histone deacetylase inhibitor in patients with advanced hematological malignancies. (7th January 2019)

Authors:
von Tresckow, Bastian; Sayehli, Cyrus; Aulitzky, Walter E.; Goebeler, Maria‐Elisabeth; Schwab, Matthias; Braz, Eunice; Krauss, Babett; Krauss, Rolf; Hermann, Frank; Bartz, René; Engert, Andreas
Journal:
European journal of haematology
Issue:
Volume 102:Number 2(2019)
Page Start:
163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Poor efficacy and tolerability of R‐CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. Issue 12 (26th September 2014)

Authors:
Langerbeins, Petra; Busch, Raymonde; Anheier, Nadine; Dürig, Jan; Bergmann, Manuela; Goebeler, Maria‐Elisabeth; Hurtz, Hans‐Jürgen; Stauch, Martina B.; Stilgenbauer, Stephan; Döhner, Hartmut; Fink, Anna‐Maria; Cramer, Paula; Fischer, Kirsten; Wendtner, Clemens‐Martin; Hallek, Michael; Eichhorst, ...
Journal:
American journal of hematology
Issue:
Volume 89:Issue 12(2014:Dec.)
Page Start:
E239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The identification of patient‐specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild‐type melanomas. Issue 4 (18th December 2018)

Authors:
Appenzeller, Silke; Gesierich, Anja; Thiem, Alexander; Hufnagel, Anita; Jessen, Christina; Kneitz, Hermann; Regensburger, Martina; Schmidt, Cornelia; Zirkenbach, Vanessa; Bischler, Thorsten; Schilling, Bastian; Siedel, Claudia; Goebeler, Maria‐Elisabeth; Houben, Roland; Schrama, David; Gehrig, An...
Journal:
Cancer
Issue:
Volume 125:Issue 4(2019)
Page Start:
586
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗